# A Clinical Study Evaluating the Dermal Safety of Soluble Denosumab Microneedle Patches

> **NCT07085520** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Union Hospital, Tongji Medical College, Huazhong University of Science and Technology** · enrollment: 12 (estimated)

## Conditions studied

- Osteoarthritis
- Osteoarthritis (OA) of the Knee
- Osteoporosis
- Osteoporosis (Senile)
- Healthy

## Interventions

- **DRUG:** Microneedle with 0.24mg Denosumab
- **DRUG:** Saline Microneedle Patch
- **DRUG:** Microneedle with 1.2mg Denosumab
- **DRUG:** Microneedle with 6mg Denosumab

## Key facts

- **NCT ID:** NCT07085520
- **Lead sponsor:** Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07-31
- **Primary completion:** 2025-10-31
- **Final completion:** 2026-05-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07085520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07085520, "A Clinical Study Evaluating the Dermal Safety of Soluble Denosumab Microneedle Patches". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07085520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*